Related Experiment Video
Updated: Sep 19, 2025

Modified Heterotopic Abdominal Heart Transplantation and a Novel Aortic Regurgitation Model in Rats
Published on: June 2, 2023
Left ventricular dilatation in patients with significant aortic regurgitation: association with outcome
Pilar Lopez Santi1, Jeremy Bernard2, Federico Fortuni1,3
1Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, Leiden 2300 RC, The Netherlands.
Insights
Left ventricular dilatation in aortic regurgitation patients, whether linear or volumetric, independently predicts higher mortality. Combining these measures improves risk stratification for better patient outcomes.
Area of Science:
- Cardiology
- Echocardiography
- Prognostic Biomarkers
Background:
- Left ventricular (LV) dilatation is a key prognostic factor in aortic regurgitation (AR).
- Current guidelines use LV end-systolic diameter index (LVESDi), but LV end-systolic volume index (LVESVi) may better reflect LV remodeling.
- Improved risk stratification is needed for patients with significant AR.
Purpose of the Study:
- To evaluate if combining LV linear and volumetric measures enhances risk stratification in AR patients.
- To assess the prognostic value of LVESDi and LVESVi in a multi-center AR cohort.
Main Methods:
- Multi-center study including 1070 patients with significant AR.
- Categorization into no-significant LV dilatation, discordant LV dilatation, and concordant LV dilatation based on LVESDi and LVESVi cut-off values.
- Primary endpoint: all-cause mortality; secondary endpoint: aortic valve surgery (AVS).
Main Results:
- Concordant LV dilatation showed the worst 10-year survival.
- Both discordant and concordant LV dilatation were independently associated with increased mortality compared to no significant dilatation.
- LV dilatation independently predicted outcomes even in asymptomatic patients or those with preserved ejection fraction, and both groups benefited from AVS.
Conclusions:
- LV dilatation, assessed by linear and/or volumetric measures, is an independent predictor of mortality in significant AR.
- Combining LVESDi and LVESVi provides valuable prognostic information for AR patients.
- This approach aids in risk stratification and may guide therapeutic decisions.
Aims:
Left ventricular (LV) dilatation is an important prognostic factor in patients with aortic regurgitation (AR). Although current guidelines recommend the use of LV end-systolic diameter index (LVESDi) to indicate the need for intervention, recent studies suggested that LV end-systolic volume index (LVESVi) may more accurately characterize LV remodelling.The present study aims to evaluate, in a multi-centre setting, whether combining LV linear and volumetric measures could improve risk stratification.
Methods And Results:
A total of 1070 patients (56 ± 18 years, 65% male) with significant AR were included. Cut-off values of 20 mm/m2 for LVESDi and 45 mL/m2 for LVESVi were used to identify the following groups: no-significant LV dilatation (n = 485), when both LVESDi and LVESVi were below the cut-off values; discordant LV dilatation (n = 279) if only one positive criterium was present; and concordant LV dilatation (n = 306) when both LVESDi and LVESVi were enlarged. The primary endpoint was all-cause mortality. During a median follow-up of 7.4 (IQR, 4.5-11) years, 168 patients (16%) died, and 484 (45%) underwent aortic valve surgery (AVS). Patients with concordant LV dilatation showed the worst 10-year survival (P < 0.001). Discordant (HR 2.066, 95% CI 1.295-3.298; P = 0.002) or concordant LV dilatation (HR 2.759, 95% CI 1.616-4.710; P < 0.001) was independently associated with higher mortality compared with patients with no-significant LV dilatation after adjusting for relevant clinical and echocardiographic variables and regardless of AR severity. However, both groups showed greater benefit from AVS. LV dilatation, either concordant or discordant, was also independently associated with outcome in asymptomatic patients and those with left ventricular ejection fraction > 55%.
Conclusion:
In patients with significant AR, the presence of LV dilatation detected by linear and/or volumetric measures was independently associated with increased mortality.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Mitral Regurgitation I: Introduction
Aortic Regurgitation IV: Nursing Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

